Astragaloside IV significantly ameliorates cognitive impairments induced by transient cerebral ischemia and reperfusion injury. Astragaloside IV regulates inflammatory responses by inhibiting TLR4 signaling pathway and NLRP3 inflammasome overactivation. Astragaloside IV attenuates cerebral ischemia and reperfusion injury by suppressing the overactivation of microglia.